Open Access Open Access  Restricted Access Subscription or Fee Access

Exocrine Pancreatic Insufficiency: A Review

Ashish Rao M, Kusalik Boppana, Nivedita .


“Exocrine pancreatic insufficiency”, often known as EPI, is a condition diagnosed in gastroenterology that is defined by insufficient or inaccurate pancreatic fluid secretion as well as pancreatic lipase function. The clinical symptoms as well as metabolic variations that EPI might cause can sometimes lead to outcomes that put a person's life in jeopardy. EPI is common in a variety of conditions that are not related to the pancreas, in addition to those that involve the pancreas, when and it should be recognized and promptly treated. However, there are a variety of tests offered, and the most common ones for diagnosing EPI are indirect, non-invasive procedures such as monitoring the level of faecal elastase (FE). This review paper will cover the latest research on the prevalence, diagnostic methods, and treatment of EPI, emphasizing the central role of 'pancreatic enzyme replacement therapy (PERT)' in its management.


Malnutrition, diagnosis, treatment, chronic pancreatitis, pancreatic cancer, exocrine pancreatic insufficiency

Full Text:



Whitcomb, D. C., Lehman, G. A., Vasileva, G., Malecka-Panas, E., Gubergrits, N., Shen, Y., ... & Caras, S. (2010). Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Official journal of the American College of Gastroenterology| ACG, 105(10), 2276-2286.

Pezzilli, R., Labate, A. M., Ceciliato, R., Frulloni, L., Cavestro, G. M., Comparato, G., ... & Gullo, L. (2005). Quality of life in patients with chronic pancreatitis. Digestive and liver disease, 37(3), 181-189.

Borowitz, D., Konstan, M. W., O'Rourke, A., Cohen, M., Hendeles, L., & Murray, F. T. (2007). Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. The Journal of Pediatric Pharmacology and Therapeutics, 12(1), 47-52.

Chowdhury, R. S., & Forsmark, C. E. (2003). Pancreatic function testing. Alimentary pharmacology & therapeutics, 17(6), 733-750.

Domínguez-Muñoz, J. E., Nieto, L., Vilariño, M., Lourido, M. V., & Iglesias-García, J. (2016). Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas, 45(2), 241-247.

Löhr, J. M., Dominguez-Munoz, E., Rosendahl, J., Besselink, M., Mayerle, J., Lerch, M. M., ... & HaPanEU/UEG Working Group. (2017). United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European gastroenterology journal, 5(2), 153-199.

González-Sánchez, V., Amrani, R., González, V., Trigo, C., Picó, A., & de-Madaria, E. (2017). Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-Mixed Triglyceride Breath Test versus Fecal Elastase. Pancreatology, 17(4), 580-585.

Struyvenberg, M. R., Martin, C. R., & Freedman, S. D. (2017). Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC medicine, 15(1), 29.

Vanga, R. R., Tansel, A., Sidiq, S., El-Serag, H. B., & Othman, M. O. (2018). Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 16(8), 1220–1228.e4.

Weiss, F. U., Budde, C., & Lerch, M. M. (2016). Specificity of a polyclonal fecal elastase ELISA for CELA3. PLoS One, 11(7), e0159363.

Vanga, R. R., Tansel, A., Sidiq, S., El-Serag, H. B., & Othman, M. O. (2018). Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(8), 1220-1228.

Singh, V. K., Haupt, M. E., Geller, D. E., Hall, J. A., & Diez, P. M. Q. (2017). Less common etiologies of exocrine pancreatic insufficiency. World Journal of Gastroenterology, 23(39), 7059.

Söderström, L., Rosenblad, A., Adolfsson, E. T., & Bergkvist, L. (2017). Malnutrition is associated with increased mortality in older adults regardless of the cause of death. British Journal of Nutrition, 117(4), 532-540.

Raphael, K. L., Chawla, S., Kim, S., Keith, C. G., Propp, D. R., Chen, Z. N., ... & Willingham, F. F. (2017). Pancreatic insufficiency secondary to tobacco exposure: A controlled cross-sectional evaluation. Pancreas, 46(2), 237.

Sand, J., & Nordback, I. (2009). Acute pancreatitis: risk of recurrence and late consequences of the disease. Nature reviews Gastroenterology & hepatology, 6(8), 470-477.

Huang, W., de la Iglesia-Garcia, D., Baston-Rey, I., Calvino-Suarez, C., Larino-Noia, J., Iglesias-Garcia, J., ... & Sutton, R. (2019). Exocrine pancreatic insufficiency following acute pancreatitis: systematic review and meta-analysis. Digestive diseases and sciences, 64(7), 1985-2005.

Tseng, D. S., Molenaar, I. Q., Besselink, M. G., van Eijck, C. H., Rinkes, I. H. B., & van Santvoort, H. C. (2016). Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: a systematic review. Pancreas, 45(3), 325-330.

Struyvenberg, M. R., Martin, C. R., & Freedman, S. D. (2017). Practical guide to exocrine pancreatic insufficiency–breaking the myths. BMC medicine, 15(1), 1-8.

Pham, A., & Forsmark, C. (2018). Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Research, 7. 20.DiMagno, M. J., & Forsmark, C. E. (2018). Chronic pancreatitis and small intestinal bacterial overgrowth. Pancreatology: official journal of the International Association of Pancreatology (IAP)...[et al.], 18(4), 360-362.

de la Iglesia-Garcia, D., Vallejo-Senra, N., Iglesias-Garcia, J., López-López, A., Nieto, L., & Domínguez-Muñoz, J. E. (2018). Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. Journal of clinical gastroenterology, 52(8), e63-e72.

Domínguez-Muñoz, J. E., Nieto-Garcia, L., López-Díaz, J., Lariño-Noia, J., Abdulkader, I., & Iglesias-Garcia, J. (2018). Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC cancer, 18(1), 1-8.

Roberts, K. J., Schrem, H., Hodson, J., Angelico, R., Dasari, B. V., Coldham, C. A., ... & Mirza, D. F. (2017). Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. Hpb, 19(10), 859-867.

Forsmark, C. E., Tang, G., Tuft, M., Xu, H., Hughes, S. J., & Yadav, D. (2017, November). Oral pancreatic enzyme replacement therapy (PERT) in patients with pancreatic cancer (PCa) is infrequent and suboptimal: a national level analysis. In Pancreas (Vol. 46, No. 10, pp. 1400-1400). TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA: LIPPINCOTT WILLIAMS & WILKINS. 25.Forsmark, C., Tang, G., Xu, H., & Yadav, D. (2017). Oral pancreatic enzyme replacement therapy (PERT) in chronic pancreatitis (CP) is infrequent and often suboptimal: A national level analysis. Gastroenterology, 152(5), S677.



  • There are currently no refbacks.

Copyright (c) 2023 Research & Reviews: Journal of Medical Science and Technology

This Journal archive has been shifted to: